Relafen 750, or Relafen, or Naproxcinod, or the medication represents a targeted approach to pain relief , viewed through a biochemical pharmacy perspective. A formulation, comprising naproxcinod, seeks to affect cyclooxygenase (COX) activity, specifically COX-2, even demonstrating limited inhibi